Thomson Scientific Introduces Newport Horizon Premium and Newport Vision Premium

Industry Leader in Generic Market Information Offers Two New Solutions to Boost Competitive Advantage 


PHILADELPHIA and LONDON, March 11  /PRNewswire/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the release of Newport Horizon Premium and Newport Vision Premium, designed specifically for professionals working in product selection, business development, competitive intelligence and API (Active Pharmaceutical Ingredient) sourcing.  Their use by innovator, generic and OTC pharmaceutical companies and API manufacturers worldwide will enable them to find the most appropriate product development opportunities more quickly, and allow innovators to conduct deeper analysis on emerging generic competition.

Newport Horizon Premium and Newport Vision Premium combine sales, launch, patent, patent challenge, exclusivity, chemistry, prescribing and regulatory information for more than 10,000 molecules, 18,000 companies, 67 markets and 90 patent countries worldwide with unique, early API development and manufacturing intelligence. They build on the substantial success of Horizon Global and Vision CI by adding kilogram and IU (International Units) API consumption data from IMS Health to the data and capabilities already available.  This data will now be available for thousands of drugs by region and by dose form for both the current and previous year and will allow customers to evaluate scale, consumption trends and prices for active ingredients, all of which can be difficult to estimate using sales data alone.

"As the industry authority on the global generics market, we recognize the need for authoritative generics market information that will give customers a clear competitive advantage over their competitors," said Claude Basset, vice president, PharmaChem Specialty Markets, Thomson Scientific. "We developed Newport Horizon Premium and Newport Vision Premium to help customers improve productivity, accelerate time to market, and gain that competitive edge in the generics marketplace."

Both new solutions, Newport Horizon Premium and Newport Vision Premium address the needs of large and small players in the pharmaceuticals market and feature powerful multi-criteria search functionalities. Newport Horizon Premium is aimed at helping generic, OTC and API companies in their constant struggle to build deals faster and accelerate time to market. Newport Vision Premium is focused on helping leading pharmaceutical companies evaluate the earliest signs of generic competition for their brands and identify back-up or alternative sources of API supply.

About The Thomson Corporation

The Thomson Corporation (http://www.thomson.com/) is a global leader in providing essential electronic workflow solutions to business and professional customers.  With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare.  The Corporation's common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Thomson Scientific is a business of The Thomson Corporation.  Its information solutions assist professionals at every stage of research and development-from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com. 

DATASOURCE: Thomson Scientific



CONTACT:  Eoin Bedford, Thomson Scientific, [phone],

 



Web site:  http://www.scientific.thomson.com/

http://www.thomson.com/ 

Copyright